<DOC>
	<DOCNO>NCT00394771</DOCNO>
	<brief_summary>This 4-arm study evaluate compare bleed pattern three different dos DR-1031 oral contraceptive Seasonale oral contraceptive . Study participant receive physical gynecological exam , include Pap smear . During study , participant require complete diary</brief_summary>
	<brief_title>A Study Evaluate Bleeding Patterns With Three Different Doses DR-1031 Compared Seasonale</brief_title>
	<detailed_description>This Phase 2 , prospective , multicenter , double-blinded , randomize study design evaluate compare bleed pattern woman use one three different dos DR-1031 oral contraceptive Seasonale oral contraceptive . Patients meet study entrance criterion randomly assign one four treatment group , The overall study duration approximately 9 month ; include screen period approximately 4 week , run-in period 4 week , treatment period approximately 6 month ( two,91-day cycle ) final study visit occur 14-21 day completion study drug .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Metrorrhagia</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Levonorgestrel</mesh_term>
	<mesh_term>Ethinyl estradiol , levonorgestrel drug combination</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<criteria>Premenopausal Not pregnant breastfeed Agree use backup nonhormonal contraception study period Any contraindication use oral contraceptive Pregnancy within last 3 month Smoking &gt; 10 cigarette per day</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>oral contraceptive</keyword>
	<keyword>breakthrough bleeding</keyword>
	<keyword>spot</keyword>
</DOC>